Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024
Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel, May 3, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization …